GENE ONLINE|News &
Opinion
Blog

Biologics
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
FDA OKs First Biologic for Children Under 5 With Moderate-to-Severe Atopic Dermatitis
2022-06-08
Amgen Taps Generate to Discover Multi-Target Protein Drugs in $1.9+ Billion Deal
2022-01-07
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
GenScript’s Biotech Unit, ProBio Bags $150 Million in Series A from Hillhouse Capital
2021-08-20
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top